The chlorite-based drug WF10 constantly reduces hemoglobin A1c values and improves glucose control in diabetes patients with severe foot syndrome

AIMS: The intravenous application of the chlorite-based drug solution WF10 is known to improve wound healing in patients with diabetic foot syndrome. In this retrospective study, we addressed the question, which effects are caused by this drug in patients with diabetic foot ulcers on the hemoglobin...

Descripción completa

Detalles Bibliográficos
Autores principales: Maraprygsavan, Paiboon, Mongkolsuk, Jarasporn, Arnhold, Juergen, Kuehne, Friedrich-Wilhelm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680448/
https://www.ncbi.nlm.nih.gov/pubmed/29159131
http://dx.doi.org/10.1016/j.jcte.2016.05.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680448/
https://www.ncbi.nlm.nih.gov/pubmed/29159131
http://dx.doi.org/10.1016/j.jcte.2016.05.001

Ejemplares similares